Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for Platelet Engraftment After Allo-HSCT
NCT05143892Phase 2Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of avatrombopag in Thrombocytopenia (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Percentage of participants whose PLT reaches ≥ 20*10^9/L without the need for PLT transfusion at 4 weeks. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05143892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05143892.